Back

Platform of single-molecule enzyme activity-based liquid biopsy for detection of pancreatic adenocarcinoma at early stages

Sakamoto, S.; Hiraide, H.; Mizuno, T.; Minoda, M.; Nagano, N.; Suzuki, M.; Iwakura, N.; Kashiro, A.; Nara, S.; Morizane, C.; Hijioka, S.; Honda, K.; Kagami, Y.; Watanabe, R.; Urano, Y.; Komatsu, T.

2025-08-08 biochemistry
10.1101/2025.08.07.669035 bioRxiv
Show abstract

Liquid biopsy analyzes biomolecules in biofluids to provide critical information for the early detection of diseases and the development of more effective treatment strategies. Among these biomolecules, the functional states of proteins offer particularly valuable insights due to their direct correlation with phenotypic changes. However, current approaches for assessing protein function in liquid biopsies are often limited by low detection sensitivity. Here, we present a liquid biopsy platform that analyzes single-molecule protease/peptidase activity to detect pathological alterations in enzyme function in blood samples. The platform demonstrates potential for identifying patients with early-stage (stage I-II) pancreatic ductal adenocarcinoma (PDAC).

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.